Soliton Completes Keloid POC Clinical Trial Treatments
Soliton, Inc. (SOLY)
Company Research
Source: PR Newswire
HOUSTON, Oct. 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced it has completed all patient treatments in the keloid scar proof-of-concept trial. Join our more than 200K fans here to follow the Company: https://soly-investors.comThe study, conducted by Dr. Brenda LaTowsky, Board Certified Dermatologist at Clear Dermatology & Aesthetic Center in Scottsdale, AZ, was designed to evaluate the safety and efficacy for all patients through a 12-week time point. The study will monitor and track the progress of the results at both the 6-week and 12-week timepoints from initial treatment in order to evaluate both the near-term and continued longer-term effects.Dr. Chris Capelli, President, CEO and co-founder of Soliton, commented, "We eagerly anticipate the follow-up visi
Show less
Read more
Impact Snapshot
Event Time:
SOLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOLY alerts
High impacting Soliton, Inc. news events
Weekly update
A roundup of the hottest topics